Butyrylcholinesterase: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
<StructureSection load='1p0m' size='450' side='right' scene= caption='Glycosylated human butyrylcholinesterase complex with choline, glycerol, sulfate and Cl- ions (PDB code 1p0m)'> | |||
<StructureSection load='1p0m' size='450' side='right' scene= caption=' | |||
Revision as of 12:10, 15 November 2015
FunctionButyrylcholinesterase (BChE) is an enzyme widely distributed throughout the body in humans, but particularly prevalent in serum, where it occurs as a tetramer of catalytic subunits. It is distinguished from the homologous enzyme, acetylcholinesterase, by its ability to hydrolyze the non-natural substrate butyrylcholine as well as the neurotransmitter, acetylcholine. RelevanceBChE finds medical use as a bioscavenger for overcoming organophosphate (OP) nerve agent and insecticide intoxication by interacting rapidly with the toxic agents. DiseaseBChE biological role remains obscure, but mutations in the human BCHE gene result in prolonged post-surgical apnea due to the inability of the mutant BChEs to hydrolyse the local anaesthetic, succinylcholine. |
|
3D structures of BChE3D structures of BChE
Updated on 15-November-2015
Additional ResourcesAdditional Resources
For additional information, see: Alzheimer's Disease